InvestorsHub Logo
icon url

bennyboy1

06/23/19 11:00 AM

#197662 RE: ClosetInvestor #197660

Anavex has had good results for Alzheimer's so far with efficacy! I am definitely sure we will hear MORE coming. Parkinson's and Rett Syndrome will have good results up ahead. Trials can also be stopped for outstanding results and furtherance. What I am saying is the TIMELINE with success can be much shorter than anyone imagined. This is REALITY! No guarantees at this time, but surely we have had hints up to now. In the Parkinson's Trial patients have requested it continue beyond the end. No one in their right mind asks for a continuance if the drug is not working! Of course I believe it really is working, and time and results will bring us to the PROMISED LAND!!!!
icon url

XenaLives

06/23/19 11:01 AM

#197663 RE: ClosetInvestor #197660

No, the MOA is restoration in cellular homeostasis.. We know there has been a measure of success in the P2a.

If genes affecting ABC are involved then we might get good results with A and incomplete results with B&C but still exceed SOC en toto.

Another disease may involve ABD and relief may be greater because D is more easily reversed.

If ABD is treated in a young population that is reccently diagnosed the "cure" may be more complete.

If XYZ is treated early on it may retard the aging process and have an anti-aging effect.

THESE ARE HYPOTHETICAL FOR ILLUSTRATION OF A CONCEPT ONLY.


Please - I will not argue about this.